Evidence map›Paper›PMID 30935846›Full record

ArticleUrologic oncology2019

Science in the Heartland: Exploring determinants of offering cancer clinical trials in rural-serving community urology practices.

Shellie D Ellis, Mugur Geana, Christine B Mackay, Deborah J Moon, Jessie Gills, Andrew Zganjar, Gayle Brekke, J Brantley Thrasher, Tomas L Griebling

Abstract read
In one paragraph

Article in Urologic oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Interventions to improve access to clinical trials in urologic oncology.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2023
    Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Optimizing management of acute leukemia in community centers and when to refer.Hematology. American Society of Hematology. Education Program · 2020
    Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shellie D EllisDepartment of Health Policy & Management, University of Kansas School of Medicine, Kansas City, KS; University of Kansas Cancer Center, Kansas City, KS. Electronic address: Sellis4@kumc.edu.
Mugur GeanaSchool of Journalism and Mass Communications, University of Kansas, Lawrence, KS; University of Kansas Cancer Center, Kansas City, KS.
Christine B MackayDepartment of Health Policy & Management, University of Kansas School of Medicine, Kansas City, KS; University of Kansas Cancer Center, Kansas City, KS.
Deborah J MoonDepartment of Health Policy & Management, University of Kansas School of Medicine, Kansas City, KS.
Jessie GillsDepartment of Urology, Louisiana State University, New Orleans, LA.
Andrew ZganjarDepartment of Urology, University of Kansas School of Medicine, Kansas City, KS.
Gayle BrekkeDepartment of Health Policy & Management, University of Kansas School of Medicine, Kansas City, KS.
J Brantley ThrasherDepartment of Urology, University of Kansas School of Medicine, Kansas City, KS.
Tomas L GrieblingDepartment of Urology, University of Kansas School of Medicine, Kansas City, KS; The Landon Center on Aging, Kansas University Medical Center, Kansas City, KS.

Funding

Using Integrated Omics to Identify Dysfunctional Genetic Mechanisms Influencing Schizophrenia and Sleep DisturbancesP20GM130423 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Kalyani Pyaram, Steven Allan Soper · 2019 to 2026
$21.5M
Mentored Training for Dissemination and Implemention Research in CancerR25CA171994 · NCI · WASHINGTON UNIVERSITY · PI BROWNSON, ROSS C · 2013 to 2017
$1.5M
NCI NIH HHS R25 CA171994NIGMS NIH HHS P20 GM130423
6 · The paper itself

Abstract

objectiveEngaging community urologists in referring patients to clinical trials could increase the reach of cancer trials and, ultimately, alleviate cancer disparities. We sought to identify determinants of referring patients to clinical trials among urology practices serving rural communities.

methodsWe conducted semistructured qualitative interviews based on the Theoretical Domains Framework at nonmetropolitan urology practices located in communities offering urological cancer trials. Participants were asked to consider barriers and strategies that might support engaging their patients in discussions about urological cancer clinical trials and referring them appropriately. Recorded interviews were transcribed and coded using template analysis.

resultsMost participants were not aware of available trials and had no experience with trial referral. Overall, participants held positive attitudes toward clinical trials and recognized their potential roles in accrual, but limited local resources reduced opportunities for offering trials. Most participants expressed a need for increased human, financial, and other resources to support this role. Many participants requested information and training to increase their knowledge of clinical trials and confidence in offering them to patients. Participants highlighted the need to build efficient pathways to identify available trials, match eligible patients, and facilitate communication and collaboration with cancer centers for patient follow-up and continuity of care.

conclusionsWith adequate logistical and informational support, community urology practices could play an important role in clinical trial accrual, advancing cancer research and increasing treatment options for rural cancer patients. Future studies should explore the effectiveness of strategies to optimize urology practices' role in clinical trial accrual.

Indexed as

AdultClinical Trials as TopicFemaleHumansMaleMiddle AgedRural PopulationUrologic NeoplasmsCancer care deliveryClinical trialsCommunity practiceImplementation sciencePhysician recommendationUrological cancer

Identifiers

PMID30935846
PMCPMC6661185

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.